Orchestra BioMed Holdings, Inc.
OBIO
$2.61
-$0.17-6.12%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -61.02M | -57.69M | -55.58M | -51.64M | -49.12M |
| Total Depreciation and Amortization | 308.00K | 296.00K | 291.00K | 290.00K | 287.00K |
| Total Amortization of Deferred Charges | 31.00K | 3.00K | 39.00K | 76.00K | 112.00K |
| Total Other Non-Cash Items | 10.89M | 8.91M | 8.94M | 7.14M | 5.90M |
| Change in Net Operating Assets | -765.00K | 482.00K | 1.73M | -725.00K | -3.31M |
| Cash from Operations | -50.56M | -47.99M | -44.58M | -44.86M | -46.13M |
| Capital Expenditure | -289.00K | -180.00K | -131.00K | -51.00K | -78.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -602.00K | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 13.98M | 50.17M | 62.51M | 60.13M | 10.77M |
| Cash from Investing | 13.09M | 49.99M | 62.38M | 60.08M | 10.69M |
| Total Debt Issued | 15.00M | -- | -- | -- | -- |
| Total Debt Repaid | -- | -10.85M | -10.85M | -10.85M | -10.85M |
| Issuance of Common Stock | 15.28M | 15.38M | 346.00K | 261.00K | 254.00K |
| Repurchase of Common Stock | -550.00K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -554.00K | 0.00 | 0.00 | 0.00 | 56.81M |
| Cash from Financing | 29.17M | 4.53M | -10.50M | -10.59M | 46.22M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -8.30M | 6.53M | 7.30M | 4.63M | 10.78M |